Separately, in a 72-week clinical trial of tirzepatide (15 mg), paired with diet/exercise, patients without diabetes and with BMI 30, or BMI 27 and a weight-related diagnosis, lost 20% of their body weight in 1 year
Dr Al-Aly stressed that any conversations around the risks vs
The duration depends on your prescribed weekly dose
As one expert was recently quoted, The risk-benefit calculus for these drugs is very different for older adults than younger people, because the risk, the potential for harm, is greater. So, for example, quick and significant weight loss in an older adult could trigger concerns about muscle loss, frailty, and fall risks, along with bone density concerns
This can cause side effects like joint pain, water retention, and possibly increased blood pressure